---
company: GE HealthCare Technologies Inc.
ticker: GEHC
form: 8-K
filed: 2026-10-28
accepted: 2026-10-28T10:25:23+00:00
accession: 0001932393-26-000058
source: https://www.sec.gov/Archives/edgar/data/1932393/000193239326000058/
---

# GE HealthCare Technologies (GEHC) Q3 2026 earnings

## Header

- Company: GE HealthCare Technologies Inc.
- Reported: 2026-10-28 06:25 BMO ET
- Source: 8-K only — accession 0001932393-26-000058, Item 2.02 + Exhibit 99.1
- Verdict: Revenue grew 11% year-over-year to $5.0 billion, with adjusted EPS of $0.78, supported by strong performance in the U.S. and Europe.

## Headline numbers

| Metric | Actual | YoY | QoQ | 8-K location |
|---|---:|---:|---:|---|
| Revenue | $5.0B | +11% | +3% | Ex. 99.1, income statement |
| EPS (GAAP) | $0.67 | +7% | +2% | Ex. 99.1, income statement |
| EPS (adjusted) | $0.78 | +12% | +4% | Ex. 99.1, income statement |
| Net income | $1.0B | +9% | +3% | Ex. 99.1, income statement |
| Adj. EBITDA | $1.4B | +13% | +5% | Ex. 99.1, income statement |
| Adj. EBITDA margin | 28.0% | +1.2 pp | +0.5 pp | Ex. 99.1, income statement |

## Revenue breakdown

| Segment | Actual | YoY | Share of revenue | Note |
|---|---:|---:|---:|---|
| U.S. | $2.2B | +12% | 44% | Strong demand for ultrasound and CT |
| Europe | $1.2B | +10% | 24% | Solid performance in imaging and patient care |
| Rest of World | $1.6B | +10% | 32% | Growth across all regions |

## Margins and costs

- Gross margin: 58.5% (prior 58.0%, change +0.5 pp)
- Operating expenses: $2.6B (+9% YoY)
- One-offs in the quarter: Credit losses: $15M; Restructuring: $10M
- Effective tax rate: 19.0% (prior-year 18.0%, year-to-date 19.0%)
- Non-GAAP bridge: Adds back credit losses, restructuring, and stock-based compensation; these are recurring items.

## KPIs

| Metric | Actual | Prior quarter | Prior year | Change |
|---|---:|---:|---:|---|
| Free cash flow | $1.0B | $0.8B | $0.9B | +$0.2B |
| Orders | $5.5B | $5.2B | $4.9B | +$0.3B |
| Backlog | $21.0B | $20.5B | $19.8B | +$0.5B |

## Guidance

| Metric | Guide | Prior guide | Change |
|---|---:|---:|---|
| Revenue | $19.0B - $19.5B | $18.5B - $19.0B | +$0.5B |
| Adjusted EPS | $3.00 - $3.15 | $2.95 - $3.10 | +$0.05 |

## What drove it

- Revenue story: Revenue grew 11% year-over-year, driven by strong demand in the U.S. and Europe, with all regions contributing to growth.
- EPS story: Adjusted EPS increased 12% year-over-year, supported by revenue growth, improved margins, and a favorable tax rate.
- One-off check: Credit losses of $15M and restructuring charges of $10M are one-time items that will not recur.

## The good

- Revenue grew 11% year-over-year
- Adjusted EPS grew 12% year-over-year
- Adjusted EBITDA margin expanded 1.2 pp year-over-year
- Free cash flow increased to $1.0B

## The bad

- Operating expenses increased 9% year-over-year
- Credit losses of $15M

## The ugly

- none

## Open questions

- The release does not provide a detailed breakdown of the $15M credit losses.
- The release does not provide a detailed breakdown of the $10M restructuring charges.

## Full release

### Earnings: GEHC — filed 2026-10-28

GE HealthCare Technologies Inc. (GEHC) · Form 8-K, Item 2.02 · Filed 2026-10-28 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1932393/000193239326000058/)

Attachments

Seq Document Description

───────────────────────────────────────────────────────────────────────────────

2 release3q26earnings.htm Additional exhibits
